NP & PA’s Communication Preferences During the …...• Peer Influencer Marketing Platform:Our industry-supported omni-channel solution delivers best-in–class engagement programs

© 2020 All rights reserved | Confidential | For POCN™ use only

NP & PA’s Communication Preferences During the Coronavirus Pandemic (COVID-19)

MARKET RESEARCH SURVEYRESULT

For additional information or questions please contact Richard Zwickel at [email protected]

https://www.pocn.com/contact-us

http://pointofcarenetwork.com

https://www.pocn.com/contact-us


© 2020 All rights reserved | Confidential | For POCN™ use only 3


• 394,833 NPs & PAs – Profiled w/Dx & Rx & Influence Mapped

• 5,000+ NP & PA KOL Ambassadors - 28 TAs & Local GEOs

• America’s Top NP & PA – Peer Nomination & Social Graphing

PROPRIETARY DATA - TOTAL OFFICE & TrueRxTM

• 240M Dx Claims – ALL HCPs w/90% of all Rx Claims

• IP – 4 Patents / Re-attribution, Affiliations, Best of breed /Site of Service

and Inferred Specialty Designations for NPs & PAs

• KOL Identification & Mapping – TA, GEO, IDN, Inferred Specialty

LEARNResources to help career, maintain license, reputation and keep abreast of the latest healthcare news & trends

EARNCareer/Job board, Education and Research opportunities that compensate participants for their time and thought leadership

CAREResources that assist in supporting both practice and patient decision support & education

CONNECTOpportunities to connect with peers, recognize and celebrate industry leaders, and broaden professional networks

.

.

DATA DRIVEN OMNI-CHANNEL SOLUTIONS

.

.

NP & PA PEER INFLUENCER PLATFORM

4


OBJECTIVES: COVID-19 NP/PA SURVEY

During Covid-19 Pandemic:

• Understand what type of communicationsand medical information NP & PAsprefer

• Uncover how NP & PAs would like to receive communications and information

• Determine how pharma can appropriately support and add value to NPs andPAs

• Confirm what type of disease state or productinformation they would like to receive frompharma

• Solidify how outbound pharma communications can be done in a respectful & desiredmanner

All questions and answers were cast within the context of Covid-19 Pandemic


BACKGROUND

6

153 responses(49 of which werecomplete)

45%were Nurse Practitioners

54%were PAs

The majority of respondentshave been in practice

>6 yearswith the largest subset being in practice between 11-15 years

Participants were asked if they were interested in information from Life ScienceCompanies,

53%respondents said no, and the surveywas terminated.


NP / PA SPECIALTYBREAKDOWN



ROLES & RESPONSIBILITIES HAVE SHIFTED AND CHANGED – TELEMEDICINE EMERGES AS PREDOMINANT SHIFT

• The majority of write-in responses mentioned an increase in TeleMedicine, and telephone visits

• Many have had an increase in responsibilities including taking on the role of nurse and MA in office due to furloughs

• Increase in hours listed often

• Decrease in patient volume in clinics; postponing routine follow-ups• Deployment to other areas including respiratory clinics, ER duty, cross-

training – some mentioned this opened up opportunities for them thatPPO had previously denied

• Small majority mentioned no change


PRESCRIBING AND TREATMENT GUIDELINES, PATIENT ASSISTANCE PROGRAMS, DISEASE/CONDITION INFO, SAMPLES, AND COPAY CARDS

Q6. Please rank the following information and services you would be interested in receiving fromLife Science Companies (Pharmaceutical/Biotechnology/Med Device).


SIDE EFFECT PROFILES, PRICING INFORMATION, CLINICAL RESEARCH PUBLICATIONS, DOSING AND TITRATION, ADMINISTRATION INSTRUCTIONS

Q7. Please indicate what type of information you would be receptive tohearing about at this time regarding pharmaceutical products.


EMAIL AND JOURNALS RANKED HIGHEST OVERALL FOR MOST DESIRED METHOD TO LEARN NEW INFORMATION ABOUT A THERAPEUTICTX

Q8. What is your desired method to learn new information abouttherapeutic treatments?


95% OF NP/PA REPORT TELEMEDICINE HAS IMPACTED THEIR DAILY INTERACTION WITH PATIENTS

Q9. Towhat level has telemedicine impacted daily interaction with the following: (a)patients (b) how you make treatment decisions (c) how you run your practice?


REMOTE ENGAGEMENTS HAVE INCREASED:TELEMEDICINE WITH PATIENTS, DIAGNOSIS, TREATMENT DECISIONS, AND VIDEO APPOINTMENTS

Q10.Haveyou had an increase in any remote engagements asa result of the Pandemic?


“Use more patient educationmaterials””

It has made me realize how much can be accomplished withoutactually seeing a patient in person and outcomes have remainedneutral “ "This is our way of lifenow "

“More streamlined now"” I have more virtual visits than officevisits I am a bit more liberal with prescribing Increased treatment based onsymptoms ”

“Making more clinicaldecisions independently”

"Treating patients via telemedicine empirically for the most common disease

and if didn’t work then consider seeing the patient with an actual officevisit"

"Simplifying treatment changes mostly with olderpatients"

TELEMEDICINE IS ACCOMPLISHING A LOT; PATIENT EDUCATION

Q14. lf telemedicine hashad an impact, tell us how ithasaffected your treatment decisions: [opentext]


TELEMEDICINE IS OF VALUE, BUT MISS PHYSICAL EXAM & TESTINGRelying more on patient information rather than [my]own exam Unreliable blood pressure – unable to titrate medications Limited testing and lab work

Following guidelines, lack of exam input (lung sounds,etc.)Some patients still need to come in for exam to make definitive treatment plan The treatment is different as you base more on history obtainedHard to make decisions based on opinion and not actually listening to heart and chestMuch heavier weight placed on history via HPI and ROS; empirical data and less diagnostics Unable to swab for strep; unable to gain insight from physical examI have to be more flexible since physical exam is mostly absent Unable to do physical exam in detail

More difficult to treatLess likely to use immune suppressing chemotherapy


WITH SOME, CRITICAL CARE SETTING TELEMEDICINE PRESERVES PPE

In the critical care setting we have used telemedicine carts to place in intubated patient rooms.

We utilize Bluetooth capable stethoscopes that nursescan place on their chests and we can do an assessment from outside of the roompreserving PPE.


Majority believe they will have an increased use of telemedicine• Especially for those physically incapable of coming into the office/housebound• Sees Telemedicine as more convenient for patients• Use to conform to patients needs, demands, interest• Use to reduce in person visits

Q16. Once you are able to return to “normal” practice (post-COVID-19), how do you envision your practicechanging? (i.e., using Telemedicine more often, no changesat all, etc.): [open text]

ONCE WE RETURN TO “NORMAL” MAJORITY WILL CONTINUE TO USE TELEMEDICINE

Majority will continue to use telemedicine for follow-ups

or urgent care issues.Some will balance betweena

maintained heightened use…but will still rely mostly on their in-

personpractice.

Others will go back toall in-person appointments post

COVID-19.


>40% OF NP/PA WOULD LIKE TO GARNER CONFERENCE-STYLE MEDICAL EDUCATION FROM WEBCASTS & EMAIL ENGAGEMENT

Q11.Withconferencesgettingcancelledat this time, howwouldyoulike to garnerconference-style (non-CME) medical education, and how would you like Life Science Companies (Pharmaceutical/Biotechnology/MedDevice) to deliver it to you?


NP/PA OPEN TO NEW IDEAS TO VIEW CONFERENCE-STYLE CONTENT

Q12. Are there any other ways that you would like to garnerconference-style (non-CME) medical education?

• App style that can be done on my own time• Text messaging for content and links• Thumb drive with information or an emailed link to watchpre-recorded• Face to face• Dedicated web sites

– With informationand quizzes• In person reps• Podcasts• Video Conferencing / Zoom / Microsoft Teams / WebEx• Any electronic media

© 2020 All rights reserved | Confidential | For POCN™ use onlyQ13.Wouldyoubeopento avirtual videosales call with yoursalesrepresentative, includingameal through a deliveryservice?

46% OPEN TO A VIRTUAL VIDEO SALES CALL INCLUDING MEAL DELIVERY

71%

of NPs and PAs feel supported by theirpharmaceutical manufacturers

Most respondents gave anaverage rating when askedLife Science Companies aresupporting their patients.


VALUABLE NEW CHANNELS FOR PRODUCT INFORMATION

Q15. Have you found yourself using different channels to get productinformation during this time, than your previous practices? If so, whatchannels have you found useful: (open text box)


• Baggies with hand made masks, PPE, etc. with info promoting their product with the PPE

• Notes, letters• Sending lunch• Drop off handouts• Email and provide reassurance that meds will be

delivered on time• Texts to my personal phone promoting their product

and reaching out to let me know they were thinking of my patients and me during this time

• Calling to offer support• Sent patient education materials• Kind thoughts

Q17.Whatoutreachhaveyouseenfrompharmareps?(Checkall that apply.) Q18.Whatother methodsof outreachfrompharmarepshaveyouseen?Q19.Whathaveyour favorite repsdoneduringthis time to helpsupport you?

96% OF NPS AND PAS HAVE SEEN EMAIL OUTREACH FROM THEIR REPS


Concern about visiting a pharmacy in person

Loss of job/incomeconcerns Manufacturingability/stock outages

Have not called/Noconcern

40

35

30

25

20

15

10

5

0

Q22. What percentage of your patients are reaching out to you with concernsabout obtaining their medications as a result of the impact of COVID-19? (totalshould equal 100%)

PATIENT CONCERNS ABOUT OBTAININGMEDICATIONS


Q23. Please rate how well Life Science Companies (Pharmaceutical/Biotechnology/Med Device) are supporting you and your patients during this timeQ24. As an NP/PA specifically, do you feel supported by your pharmaceutical manufacturers at this time?

72% OF NP & PA RESPONDENTS FEEL SUPPORTED BY PHARMA


• Financial assistance, pricing can be an issue– Providing assistance with medications–Coupon cards – send more links or email to print off couponcard– Copay Cards

• Samples–Being able to still sent samples that wecould pick up at door

or havemailed• Educational information

– Mail, email or text education and/or links with information– Relevant clinical studies– Provide information online for patients

Q25. What more can pharmaceutical companies do to support you and your patients during this challenging and unprecedented time? (for example, samples, financialassistance, coupons, or other ideas)

• Masks & PPE• Being there if I needthem• Calling patients to check in on them• Keep email lines of communication

open

WHAT MORE CAN PHARMA DO TO SUPPORT NP AND PAS DURING COVID-19 PANDEMIC


• Informative emails• Mailing c2 meds to my home• Assistance with medications• Remote lunches• Ability to send samples without having to stop by the clinic

• Telemedicine support• Video calls/visits• Rapid development of treatment options for the future –vaccine

Q26. Overall, what new or innovative ideas from pharma have you seen or experienced during the pandemic that you like the most:

NEW AND INNOVATIVE IDEAS DURING COVID-19


OVERALL

• Email• WebCasts• Peer-to-Peer Engagements• Medical Education• Patient Education• Samples• Financial Assistance• Social Media• Texting

© 2020 All rights reserved | Confidential | For POCN™ use only 28


1.AANP and AAPA sample survey reports2.. https://oaapn.org/2017/11/2017-nurse-practitioners-infographic/3.https://www.researchgate.net/publication/279988718_Comparing_Advanced_Practice_Providers_

and_Physicians_as_Providers_of_e-Visits 4.https://www.spherixglobalinsights.com/advanced-practice-providers-treat-significantly-more-of-

their-multiple-sclerosis-patients-with-monoclonal-antibody-disease-modifying-therapies-compared-to-neurologists-in-the-us/

5.https://www.ncbi.nlm.nih.gov/pubmed/296412386.6. POCN survey June 2020

1

NP/PA PRESCRIBING POWER

Virtually all (95.7%) NPs prescribe pharmacologic agents - writing an average of 23 prescriptions per day.1 Similarly, more than 94% of PAs prescribe medications for both acute and chronic illnesses.2

NPs & PAs prescribe more frequently than MDs for some drugsand therapeutic areas as well as during e-visits.3-5

5

of APPs see their own distinct set of patients

physicians do not typically see.560%

INDEPENDENCE AND AUTONOMY• 9 in 10 NPs & PAs said they make

autonomous treatment decisions6

• 79% said they influence the physicians in their practice6

29

https://oaapn.org/2017/11/2017-nurse-practitioners-infographic/

https://www.ncbi.nlm.nih.gov/pubmed/29641238


198,200

38,050

30,024

23,536

20,096

18,521

12,865

9,292

9,237

8,451

8,176

7,688

3,779

3,654

3,166

3,115

2,983

NP & PA NETWORKTA & GEO PEER INFLUENCER PLATFORM

ONCOLOGY (APRN, ONC NURSE, NURSE NAVIGATOR, NP and PA)

CV, NEPH & ENDO, OBESITY

RETAIL MEDICINE & URGENT CARE

EM & HOSPITAL

OBGYN/WOMENS HEALTH

PSYCHIATRY

DERMATOLOGY

RHEUMATOLOGY

PEDIATRICS

RESPIRATORY

ORTHO

ID & HIV

GASTRO

UROLOGY

NEUROLOGY

ALLERGY

394,833NPs & PAs

(OPT IN AS OF 4.30.20)

198,200PRIMARY CARE

196,633SPECIALTY CARE

93% USANPs & PAs

PRIMARY CARE, INTERNAL MEDICINE GENERAL PRACTICE, FAMILY PRACTICE

30


WHAT MAKES POCN UNIQUE

• POCNs Peer Driven Network: 394,880 opt-in NPs & PAs with NPI#, patient panel, provider collaborations, affiliations, peer influence, referral patterns, AmericasTop NP & PA peer nominations, provider location

• Data as a Service- DaaSToolkitTM : Real-time prescribing behaviors with group practice values aligned to best of breed contact information and diagnostic codes coupled with 240,000,000 million patient lives

• TrueRxTM : Re-attributes NP & PA prescribing enabling a true understanding of the entire office or practice

• Impact Mapping : KOL ambassador network spans over 5,000 NP & PA local, regional & national leaders that we leverage to deliver credible information from a community of peers

• Peer Influencer Marketing Platform: Our industry-supported omni-channel solution delivers best-in–class engagement programs backed by our data and ROI deliverables

• InsightsENGINE: Research codifies prescribing habits and treatment behaviors to enable precise identification of barriers and opportunities to drive changes in clinician behaviors

31

Documents

NP & PA’s Communication Preferences During the …...• Peer Influencer Marketing Platform:Our industry-supported omni-channel solution delivers best-in–class engagement programs